July 29, 2024

 

 

Re:	AC Immune SA Registration Statement on Form F-3 Filed on March 14, 2024 Registration No. 333-277940

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on July 31, 2024 or as soon thereafter as is practicable.

 

Sincerely,

 

 

AC Immune SA
By:	/s/ Andrea Pfeifer
	Name: Andrea Pfeifer
	Title: Chief Executive Officer
By:	/s/ Christopher Roberts
	Name: Christopher Roberts
	Title: Chief Financial Officer

 

 

Via EDGAR